1992 Help me understand this report
Suppression of experimental autoimmune myasthenia gravis with new immunosuppressants: 15-deoxyspergualin and actinobolin
Search citation statements
Paper Sections
Select...
1
Citation Types
0
1
0
Year Published
1995
2017
Publication Types
Select...
4
2
Relationship
0
6
Authors
Journals
Cited by 7 publications
(1 citation statement)
References 18 publications
0
1
0
“…An impor tant aspect of deoxyspergualin action is its ability to sup press the established disease process in many of these models [24,25,27,30,34,36,38]. Combinations of deox yspergualin with other immunosuppressive drugs have provided greater protection than monotherapies in sever al models.…”
Section: Human Transplantationmentioning
confidence: 99%
“…An impor tant aspect of deoxyspergualin action is its ability to sup press the established disease process in many of these models [24,25,27,30,34,36,38]. Combinations of deox yspergualin with other immunosuppressive drugs have provided greater protection than monotherapies in sever al models.…”
Section: Human Transplantationmentioning
confidence: 99%
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
